Veronica J. Peschansky

Veronica J. Peschansky

Auto-generated profile, based on publicly available information

Veronica J. Peschansky

Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2013 in Epigenetics
Verified
Journal Article
Open access
VPVeronica J Peschansky
Veronica J Peschansky
Claes WahlestedtClaes Wahlestedt
Claes Wahlestedt
Epigenetic regulation of gene expression is an increasingly well-understood concept that explains much of the contribution of an organism’s environment and experience to its biology. However, discussion persists as to which mechanisms can be classified as epigenetic. Ongoing research continues to uncover novel pathways, including the important role of non-protein coding RNA transcripts in epigenetic gene regulation. We know that the majority of human and other mammalian transcripts are not translated but that many of these are nonetheless functional. These non-coding RNAs (ncRNAs) can be short (< 200 nt) or long (< 200 nt) and are further classified by genomic origin and mechanism of action. We discuss examples of ncRNAs that interact with histone modifying complexes or DNA methyltransferases to regulate gene expression, others that are targets of these epigenetic mechanisms, and propose a model in which such transcripts feed back into an epigenetic regulatory network.

25 June 2015 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
CPChiara Pastori
Chiara Pastori
PKPhilipp Kapranov
Philipp Kapranov
CPClara Penas
Clara Penas
VPVeronica Peschansky
Veronica Peschansky
Claude-Henry VolmarClaude-Henry Volmar
Claude-Henry Volmar
Claes WahlestedtClaes Wahlestedt
Claes Wahlestedt
Significance: Glioblastoma Multiforme (GBM) is the most common and deadliest primary brain tumor in adults. As the median survival is approximately 14 mo there is an urgent need for novel therapies. Epigenetic modulators such as bromodomain and extraterminal (BET) proteins are important therapeutic targets in GBM. Bromodomain inhibitors (including I-BET151) suppress proliferation by repressing oncogenes and inducing tumor suppressor genes through unidentified pathways. Here we demonstrate that HOTAIR (HOX transcript antisense RNA) is overexpressed in GBM, where it is crucial to sustain tumor cell proliferation, and that inhibition of HOTAIR by I-BET151 is necessary to induce cell cycle arrest in GBM cells. Our study outlines the mechanism of action underlying the antiproliferative activity of I-BET151, showing for the first time, to our knowledge, that the oncogenic long noncoding RNA HOTAIR is a major target.

5 September 2013 in Human Genetics
Verified
Journal Article
Open access
PDF file
CPChiara Pastori
Chiara Pastori
VPVeronica J. Peschansky
Veronica J. Peschansky
DBDeborah Barbouth
Deborah Barbouth
AMArpit Mehta
Arpit Mehta
JSJose P. Silva
Jose P. Silva
Claes WahlestedtClaes Wahlestedt
Claes Wahlestedt
The majority of the human genome is transcribed but not translated, giving rise to noncoding RNAs (ncRNAs), including long ncRNAs (lncRNAs, >200 nt) that perform a wide range of functions in gene regulation. The Fragile X mental retardation 1 (FMR1) gene is a microsatellite locus that in the general population contains <55 CGG repeats in its 5′-untranslated region. Expansion of this repeat region to a size of 55-200 CGG repeats, known as premutation, is associated with Fragile X tremor and ataxia syndrome (FXTAS). Further expansion beyond 200 CGG repeats, or full mutation, leads to FMR1 gene silencing and results in Fragile X syndrome (FXS). Using a novel technology called “Deep-RACE”, which combines rapid amplification of cDNA ends (RACE) with next generation sequencing, we systematically interrogated the FMR1 gene locus for the occurrence of novel lncRNAs. We discovered two transcripts, FMR5 and FMR6. FMR5 is a sense lncRNA transcribed upstream of the FMR1 promoter, whereas FMR6 is an antisense transcript overlapping the 3′ region of FMR1. FMR5 was expressed in several human brain regions from unaffected individuals and from full and premutation patients. FMR6 was silenced in full mutation and, unexpectedly, in premutation carriers suggesting abnormal transcription and/or chromatin remodeling prior to transition to the full mutation. These lncRNAs may thus be useful as biomarkers, allowing for early detection and therapeutic intervention in FXS and FXTAS. Finally we show that FMR5 and FMR6 are expressed in peripheral blood leukocytes and propose future studies that correlate lncRNA expression with clinical outcomes.

1 March 2008 in Neuroscience
Verified
Journal Article
Closed access
TBT.J. Burbridge
T.J. Burbridge
YWY. Wang
Y. Wang
AVA.J. Volz
A.J. Volz
VPV.J. Peschansky
V.J. Peschansky
LLL. Lisann
L. Lisann
GRG.D. Rosen
G.D. Rosen

13 August 2009 in Cerebral Cortex
Verified
Journal Article
Open access
PDF file
VPVeronica J. Peschansky
Veronica J. Peschansky
TBTimothy J. Burbridge
Timothy J. Burbridge
AVAmy J. Volz
Amy J. Volz
CFChristopher Fiondella
Christopher Fiondella
ZWZach Wissner-Gross
Zach Wissner-Gross
GRGlenn D. Rosen
Glenn D. Rosen
We investigated the postnatal effects of embryonic knockdown and overexpression of the candidate dyslexia gene homolog Kiaa0319. We used in utero electroporation to transfect cells in E15/16 rat neocortical ventricular zone with either 1) small hairpin RNA (shRNA) vectors targeting Kiaa0319, 2) a KIAA0319 expression construct, 3) Kiaa0319 shRNA along with KIAA0319 expression construct (“rescue”), or 4) a scrambled version of Kiaa0319 shRNA. Knockdown, but not overexpression, of Kiaa0319 resulted in periventricular heterotopias that contained large numbers of both transfected and non–transfected neurons. This suggested that Kiaa0319 shRNA disrupts neuronal migration by cell autonomous as well as non–cell autonomous mechanisms. Of the Kiaa0319 shRNA–transfected neurons that migrated into the cortical plate, most migrated to their appropriate lamina. In contrast, neurons transfected with the KIAA0319 expression vector attained laminar positions subjacent to their expected positions. Neurons transfected with Kiaa0319 shRNA exhibited apical, but not basal, dendrite hypertrophy, which was rescued by overexpression of KIAA0319. The results provide additional supportive evidence linking candidate dyslexia susceptibility genes to migrational disturbances during brain development, and extends the role of Kiaa0319 to include growth and differentiation of dendrites.

1 April 2015 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
SMStavros N. Moysidis
Stavros N. Moysidis
KAKaren Alvarez-Delfin
Karen Alvarez-Delfin
VPVeronica J. Peschansky
Veronica J. Peschansky
ESEnrique Salero
Enrique Salero
AWAlejandra D. Weisman
Alejandra D. Weisman
JGJeffrey L. Goldberg
Jeffrey L. Goldberg